Etoposide activates CD8+ T cell anti-tumor immunity in osteosarcoma through MHC I upregulation via tumor-secreted IL-33 mediated signaling
Xin He, Hanjun Li, Haoyu Wang, Dongqing Zuo, Haoru Dong, Haoran Mu, Binghui Yang, Yining Tao, Xiyu Yang, Bowen Zhao, Tao Zhang, Yafei Jiang, Zhuoying Wang, Hongsheng Wang, Liu Yang, Yingqi Hua, Zhengdong Cai, Chongren Wang, Mengxiong Sun, Jun Gui, Wei Sun · 2025
Read Etoposide activates CD8+ T cell anti-tumor immunity in osteosarcoma through MHC I upregulation via tumor-secreted IL-33 mediated signaling by Xin He, Hanjun Li, Haoyu Wang, Dongqing Zuo, Haoru Dong, Haoran Mu, Binghui Yang, Yining Tao, Xiyu Yang, Bowen Zhao, Tao Zhang, Yafei Jiang, Zhuoying Wang, Hongsheng Wang, Liu Yang, Yingqi Hua, Zhengdong Cai, Chongren Wang, Mengxiong Sun, Jun Gui, Wei Sun (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12718598.txt.
Description
Xin He and a large team reported in two thousand twenty-five that a standard chemotherapy drug can wake immune attack in osteosarcoma, a bone cancer prone to spread and return. Immune drugs have disappointed in this cancer so far. Screening common drugs, they found etoposide raises a display molecule that lets killer T cells recognize tumor cells.
A tumor-released signal carried much of the effect, boosting T cell killing in lab and animal models. Combining etoposide with an immune checkpoint drug was also tested. The work points to pairing old chemotherapy with immunotherapy instead of discarding either. Bone cancer teams gain a concrete combination to study.
Catalog record
| CREATOR | Xin He, Hanjun Li, Haoyu Wang, Dongqing Zuo, Haoru Dong, Haoran Mu, Binghui Yang, Yining Tao, Xiyu Yang, Bowen Zhao, Tao Zhang, Yafei Jiang, Zhuoying Wang, Hongsheng Wang, Liu Yang, Yingqi Hua, Zhengdong Cai, Chongren Wang, Mengxiong Sun, Jun Gui, Wei Sun |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 62 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |